
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.69 | 3.78 | 0.09 |
Stocks | 93.18 | 93.18 | 0.00 |
Other | 3.13 | 3.30 | 0.17 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.44 | 20.38 |
Price to Book | 4.11 | 3.38 |
Price to Sales | 2.97 | 2.68 |
Price to Cash Flow | 15.55 | 14.08 |
Dividend Yield | 1.04 | 1.81 |
5 Years Earnings Growth | 18.00 | 12.13 |
Name | Net % | Category Average |
---|---|---|
Industrials | 27.53 | 18.89 |
Technology | 20.25 | 19.82 |
Consumer Cyclical | 18.93 | 13.84 |
Healthcare | 13.77 | 12.40 |
Financial Services | 11.50 | 14.76 |
Communication Services | 4.11 | 5.72 |
Basic Materials | 2.12 | 6.43 |
Energy | 1.80 | 2.44 |
Number of long holdings: 38
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Taiwan Semicon | TW0002330008 | 5.25 | 785.00 | -3.80% | |
Novo Nordisk B | DK0062498333 | 4.26 | 420.0 | +2.55% | |
Sea | US81141R1005 | 3.96 | 115.28 | -3.20% | |
Safran | FR0000073272 | 3.89 | 210.80 | -0.57% | |
SAP | DE0007164600 | 3.86 | 230.680 | +0.30% | |
Ferrari NV | NL0011585146 | 3.84 | 423.81 | -1.90% | |
Spotify Tech | LU1778762911 | 3.74 | 553.02 | -2.82% | |
AstraZeneca | GB0009895292 | 3.23 | 10,008.0 | -0.10% | |
Rolls-Royce Holdings | GB00B63H8491 | 3.11 | 693.20 | -0.06% | |
3I Group | GB00B1YW4409 | 3.05 | 3,858.00 | -0.54% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
WCM Focused International Growth In | 715.17M | 5.09 | 3.81 | 8.95 | ||
WCM Focused Global Growth Fund Inst | 579.5M | 3.44 | 12.03 | 13.12 | ||
WCM Focused Global Growth Fund Inve | 25.47M | 6.43 | 11.34 | 14.07 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review